Diagnosis and Management of Asymptomatic TB-Exposed Individuals

Initial Diagnostic Approach

For asymptomatic individuals exposed to tuberculosis, the Centers for Disease Control and Prevention recommends immediately performing tuberculin skin testing (TST) or interferon-gamma release assay (IGRA), followed by chest radiography if the test is positive, and initiating treatment for latent TB infection after excluding active disease 1, 2
High-priority contacts, such as children under 5 years, immunocompromised individuals, and HIV-infected persons, require immediate TST or IGRA testing at initial evaluation, chest radiography regardless of test results, and second TST 8-10 weeks post-exposure if initial test is negative and exposure occurred less than 8 weeks prior 1, 2
The American Thoracic Society recommends that medium-priority contacts, such as immunocompetent adults with significant exposure, undergo TST at baseline and repeat testing 8-10 weeks after last exposure, with chest radiography if TST shows ≥5 mm induration 1, 2

Before treating latent infection, active TB must be ruled out by obtaining chest radiography immediately for all positive test results, assessing for TB symptoms, and collecting sputum for mycobacteriologic testing only if chest radiograph is abnormal or symptoms are present 1, 2, 3, 4
The Centers for Disease Control and Prevention recommends that three sputum samples on different days maximize diagnostic sensitivity 4

The World Health Organization recommends that the first-line option for treating latent TB infection is 3 months of weekly rifapentine plus isoniazid (3HP), which has the highest adherence rates and reduces TB incidence by 36% in HIV-negative contacts 3
Alternative regimens include 4 months of daily rifampin alone (4R) and 3 months of daily rifampin plus isoniazid (3RH), which reduces TB incidence by 48% in HIV-positive patients 3, 5

The American Academy of Pediatrics recommends that children under 5 years with exposure initiate treatment immediately after excluding active disease, even if initial TST is negative, and continue until repeat TST at 8-10 weeks post-exposure 1
The Centers for Disease Control and Prevention recommends that HIV-infected contacts treat with full course of latent TB therapy regardless of initial TST result once active disease is excluded 6, 3

The National Institutes of Health recommends that pyridoxine (vitamin B6) be administered with all isoniazid-containing regimens to prevent peripheral neuropathy, especially critical for HIV-infected persons, pregnant women, diabetics, and alcoholics 2, 3
Liver function tests should be monitored every 2-4 weeks during treatment, and patients should be educated about hepatotoxicity symptoms 2